News

Net profit of Rossari Biotech rose 4.46% to Rs 35.10 crore in the quarter ended June 2026 as against Rs 33.60 crore during the previous quarter ended June 2025. Sales rose 28.23% to Rs 697.20 crore in the quarter ended June 2026 as against Rs 543.72 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales697.20543.72 28 OPM %11.5612.48 - PBDT73.2963.85 15 PBT47.6746.10 3 NP35.1033.60 4 Powered by Capital Market - Live News

Rossari Biotech will hold a meeting of the Board of Directors of the Company on 18 July 2026.

Rossari Biotech announced that the Annual General Meeting(AGM) of the company will be held on 20 July 2026.

Rossari Biotech announced that the Board of Directors of the Company at its meeting held on 27 April 2026, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 25%) , subject to the approval of the shareholders.

Net profit of Rossari Biotech rose 33.48% to Rs 45.97 crore in the quarter ended March 2026 as against Rs 34.44 crore during the previous quarter ended March 2025. Sales rose 18.17% to Rs 684.86 crore in the quarter ended March 2026 as against Rs 579.56 crore during the previous quarter ended March 2025.For the full year,net profit rose 9.41% to Rs 149.21 crore in the year ended March 2026 as against Rs 136.38 crore during the previous year ended March 2025. Sales rose 15.19% to Rs 2396.37 crore in the year ended March 2026 as against Rs 2080.29 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales684.86579.56 18 2396.372080.29 15 OPM %11.2811.99 -11.9312.74 - PBDT87.7765.93 33 281.64252.26 12 PBT64.2447.71 35 202.52185.19 9 NP45.9734.44 33 149.21136.38 9 Powered by Capital Market - Live News